Advertisement
Advertisement
TXG
10x Genomics, Inc. Class A Common Stock
48.13
USDSponsored
-1.30
-2.63%
Jul 31, 13:45 UTC -4
Open
TXG Earnings Reports
Positive Surprise Ratio
TXG beat 15 of 27 last estimates.
56%
Next Report
Next Week
Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$148.26M
/-$0.24
Implied change from Q1 26 (Revenue/ EPS)
-1.72%
/+140.00%
Implied change from Q2 25 (Revenue/ EPS)
-14.26%
/-185.71%
10x Genomics, Inc. Class A Common Stock earnings per share and revenue
On May 07, 2026, TXG reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.29 USD, resulting in a 66.04% surprise. Revenue reached 150.84 million, compared to an expected 147.82 million, with a 2.05% difference. The market reacted with a -3.66% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 16 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 148.26 million USD, implying an increase of 140.00% EPS, and decrease of -1.72% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tempus AI, Inc. Class A Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.04
Surprise
+71.65%
Omnicell Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.47
Actual
$0.94
Surprise
+97.11%
Butterfly Network, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.01
Surprise
+82.96%
Fulgent Genetics, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.57
Surprise
-23.61%
Pulmonx Corporation Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.28
Actual
-$0.24
Surprise
+15.97%
HeartSciences Inc. Common Stock
Report Date
Jul 23, 2026 For Q4 26
Estimate
-$0.74
Actual
-$0.87
Surprise
-16.84%
FAQ
What were 10x Genomics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.10, beating estimates by 66.04%, and revenue of $150.84M, 2.05% above expectations.
How did the market react to 10x Genomics, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved down -3.66%, changed from $22.42 before the earnings release to $21.60 the day after.
When is 10x Genomics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 06, 2026.
What are the forecasts for 10x Genomics, Inc. Class A Common Stock's next earnings report?
Based on 16
analysts, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.24 and revenue of $148.26M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement